| Ribociclib studied in …STUDIED_INderived155 of 155show fewer |
|---|
| → studied in | NCT05827081Phase 3 · recruiting Phase IIIb Study of Ribociclib + ET in Early Breast Cancer · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05867251Phase 1/Phase 2 · recruiting Study of AVZO-021 in Patients With Advanced Solid Tumors · 155 trials list this drug (71 active) | — | — | Solid Neoplasm,Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07391774Phase 3 · recruiting Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · 155 trials list this drug (71 active) | — | — | HER2-Negative Breast Carcinoma,Estrogen Receptor-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07492641Phase 3 · recruiting BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377852Phase 3 · recruiting The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07054190Phase 2 · recruiting A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384119Phase 1 · terminated Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04964934Phase 3 · active not recruiting Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085767Phase 3 · recruiting Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07174336Phase 3 · recruiting A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) · 155 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872260Phase 1/Phase 2 · active not recruiting Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03701334Phase 3 · active not recruiting A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer · 155 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05161195Phase 4 · active not recruiting Roll-over Study to Allow Continued Access to Ribociclib · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05508906Phase 1 · active not recruiting Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06065748Phase 3 · active not recruiting A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05870579Phase 1 · active not recruiting [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03424005Phase 1/Phase 2 · recruiting A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625775Phase 1 · recruiting Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors · 155 trials list this drug (71 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Malignant Lung Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07405801Phase 2 · recruiting A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07647328Phase 3 · recruiting A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04315233Phase 1 · terminated Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802759Phase 1/Phase 2 · recruiting A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06380751Phase 3 · recruiting Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726148Phase 1/Phase 2 · recruiting Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors · 155 trials list this drug (71 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03740334Phase 1 · active not recruiting Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL · 155 trials list this drug (71 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862663Phase 3 · active not recruiting Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292) · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06930859recruiting Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06188520Phase 1/Phase 2 · recruiting A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors · 155 trials list this drug (71 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06375707Phase 2 · completed First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05238922Phase 1 · active not recruiting Study of INCB123667 in Subjects With Advanced Solid Tumors · 155 trials list this drug (71 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05467891Phase 2 · recruiting Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05996107Phase 1 · recruiting Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02813135Phase 1/Phase 2 · recruiting European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors · 155 trials list this drug (71 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03439046Phase 3 · terminated Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03671330Phase 2 · completed Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116541Phase 2 · recruiting A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. · 155 trials list this drug (71 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768139Phase 1/Phase 2 · recruiting First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors · 155 trials list this drug (71 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239467Phase 1 · active not recruiting First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797531recruiting RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Early Breast Cancer in Saudi Arabia · 155 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05358249Phase 1/Phase 2 · active not recruiting Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation · 155 trials list this drug (71 active) | — | — | Colorectal Neoplasm,Lung Non-Small Cell Carcinoma,Colorectal Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563220Phase 1/Phase 2 · active not recruiting Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05843253Phase 2 · recruiting Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant · 155 trials list this drug (71 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Brain Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195227Phase 2 · recruiting Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer · 155 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06953882Phase 2 · recruiting Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008408Phase 2 · active not recruiting A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma · 155 trials list this drug (71 active) | — | — | Endometrial Carcinoma,Endometrial Endometrioid Adenocarcinoma,Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03114527Phase 2 · active not recruiting Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) · 155 trials list this drug (71 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06760637Phase 3 · active not recruiting Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05296746Phase 2 · active not recruiting Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055493Phase 3 · active not recruiting Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC · 155 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05319873Phase 1/Phase 2 · active not recruiting Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer · 155 trials list this drug (71 active) | — | — | Invasive Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06905301recruiting Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02555189Phase 1/Phase 2 · terminated Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression · 155 trials list this drug (71 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05683418Phase 1 · recruiting A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02934568Phase 2 · active not recruiting Ribociclib (LEE011) Rollover Study for Continued Access · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05664893Phase 1/Phase 2 · withdrawn Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS) · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038631available Managed Access Programs for LEE011, Ribociclib · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07164976Phase 1/Phase 2 · recruiting Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07487129Phase 4 · completed Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04417621Phase 2 · active not recruiting Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma · 155 trials list this drug (71 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02712723Phase 2 · active not recruiting Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02780128Phase 1 · terminated Next Generation Personalized Neuroblastoma Therapy · 155 trials list this drug (71 active) | — | — | Malignant Neoplasm,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05573555Phase 1/Phase 2 · active not recruiting TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02933736early Phase 1 · active not recruiting Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients · 155 trials list this drug (71 active) | — | — | Glioblastoma,Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333343Phase 1 · active not recruiting Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07002177Phase 1/Phase 2 · recruiting A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC · 155 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03090165Phase 1/Phase 2 · active not recruiting Ribociclib and Bicalutamide in AR+ TNBC · 155 trials list this drug (71 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03673124Phase 2 · active not recruiting Ribociclib and Letrozole Treatment in Ovarian Cancer · 155 trials list this drug (71 active) | — | — | Serous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03285412Phase 2 · active not recruiting CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06409390Phase 2 · recruiting Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05252416Phase 1 · terminated (VELA) Study of BLU-222 in Advanced Solid Tumors · 155 trials list this drug (71 active) | — | — | Solid Neoplasm,Carcinosarcoma,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06495164active not recruiting A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03822468Phase 2 · completed Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05429502Phase 1 · terminated Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors · 155 trials list this drug (71 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04000529Phase 1 · terminated Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies · 155 trials list this drug (71 active) | — | — | Gastrointestinal Stromal Tumor,Esophageal Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05216432Phase 1 · recruiting First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Breast Neoplasm,Solid Neoplasm,Adult Solid Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02608216Phase 1 · active not recruiting [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer · 155 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05900206Phase 2 · recruiting Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05625087Phase 2 · active not recruiting Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03294694Phase 1 · terminated Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer · 155 trials list this drug (71 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03834740early Phase 1 · completed A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection · 155 trials list this drug (71 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05759949Phase 1 · completed First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors · 155 trials list this drug (71 active) | — | — | Solid Neoplasm,Adult Solid Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974725Phase 1 · terminated A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma · 155 trials list this drug (71 active) | — | — | Melanoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958021Phase 3 · completed Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03944434Phase 2 · active not recruiting FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805812recruiting Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study · 155 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04256941Phase 2 · terminated Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study · 155 trials list this drug (71 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632045Phase 2 · completed Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657679Phase 4 · terminated Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06587789recruiting Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070301Phase 2 · completed A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors · 155 trials list this drug (71 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839823Phase 2 · completed Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03956654completed A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06481956Phase 2 · enrolling by invitation T-DM1 Combined With CDK4/6 Inhibitor Ribociclib · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03484923Phase 2 · completed Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma · 155 trials list this drug (71 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02035813Phase 2 · completed DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs). · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344472Phase 3 · unknown Detect V / CHEVENDO (Chemo vs. Endo) · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434262Phase 1 · completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors · 155 trials list this drug (71 active) | — | — | Neoplasm,Embryonal Neoplasm,Central Nervous System Embryonal Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01543698Phase 1/Phase 2 · completed A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278120Phase 3 · completed Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159066Phase 2 · completed LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma · 155 trials list this drug (71 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03477396Phase 2 · completed Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02925234Phase 2 · recruiting The Drug Rediscovery Protocol (DRUP Trial) · 155 trials list this drug (71 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02422615Phase 3 · completed Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02599363Phase 1 · completed A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02941926Phase 3 · completed Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · 155 trials list this drug (71 active) | — | — | Fibrosarcoma,Liposarcoma,Malignant Peripheral Nerve Sheath Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03555877Phase 2 · completed Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333370Phase 1 · completed A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04801966NA · terminated Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study · 155 trials list this drug (71 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05452213Phase 4 · recruiting Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients · 155 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766410Phase 2 · recruiting A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC · 155 trials list this drug (71 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03355794Phase 1 · completed A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) · 155 trials list this drug (71 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Brain Stem Glioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03237390Phase 1 · completed Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors · 155 trials list this drug (71 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05569187completed Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03056833Phase 1 · completed Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer · 155 trials list this drug (71 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02494921Phase 1/Phase 2 · completed LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC · 155 trials list this drug (71 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657343Phase 1/Phase 2 · completed An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734615Phase 1 · terminated Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02414724Phase 1 · terminated Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma · 155 trials list this drug (71 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04213404Phase 1 · unknown Ribociclib and Spartalizumab in R/M HNSCC · 155 trials list this drug (71 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02586675Phase 1 · completed TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05153135completed Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657928Phase 2 · completed Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer · 155 trials list this drug (71 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585724Phase 1 · withdrawn Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases · 155 trials list this drug (71 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03078751Phase 2 · completed Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096847Phase 3 · completed Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387020Phase 1 · completed Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors · 155 trials list this drug (71 active) | — | — | Central Nervous System Embryonal Tumor,Atypical Teratoid/Rhabdoid Tumor,Medulloblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03905343Phase 3 · terminated Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02732119Phase 1/Phase 2 · completed Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04852081unknown Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857193Phase 1 · completed Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03248427Phase 2 · completed Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer. · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02524119Phase 2 · terminated LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma · 155 trials list this drug (71 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703571Phase 1 · terminated Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01898845Phase 1 · completed A Phase I Study of LEE011 in Asian Patients · 155 trials list this drug (71 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02154776Phase 1 · completed Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. · 155 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01237236Phase 1 · completed A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. · 155 trials list this drug (71 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02088684Phase 1 · completed Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02292550Phase 1 · completed Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer. · 155 trials list this drug (71 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343172Phase 1 · completed Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma · 155 trials list this drug (71 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01781572Phase 1/Phase 2 · completed A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02607124Phase 1/Phase 2 · terminated A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy · 155 trials list this drug (71 active) | — | — | Glioma,Diffuse Intrinsic Pontine Glioma,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420691Phase 2 · completed Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin · 155 trials list this drug (71 active) | — | — | Digestive System Neuroendocrine Neoplasm,Thymus Neoplasm,Functioning Pancreatic Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02300987Phase 2 · completed A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression · 155 trials list this drug (71 active) | — | — | Teratoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050398Phase 3 · terminated A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02429089Phase 1 · terminated Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck · 155 trials list this drug (71 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01747876Phase 1 · terminated Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma · 155 trials list this drug (71 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02187783Phase 2 · completed LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) · 155 trials list this drug (71 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03179956early Phase 1 · terminated Impact of Ribociclib on Head and Neck Squamous Cell Cancer · 155 trials list this drug (71 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02345824Phase 1 · unknown Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma · 155 trials list this drug (71 active) | — | — | Glioblastoma,Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03081234Phase 3 · withdrawn Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer · 155 trials list this drug (71 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096912Phase 2 · unknown A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma · 155 trials list this drug (71 active) | — | — | Liposarcoma,Soft Tissue Sarcoma,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02571829Phase 2 · unknown A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma · 155 trials list this drug (71 active) | — | — | Liposarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01777776Phase 1/Phase 2 · terminated Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. · 155 trials list this drug (71 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01919229Phase 2 · terminated A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1) · 155 trials list this drug (71 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |